ATNM
Price
$1.73
Change
-$0.05 (-2.81%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
55.53M
83 days until earnings call
RVXCF
Price
$0.08
Change
+$0.01 (+14.29%)
Updated
Aug 29 closing price
Capitalization
21.3M
Interact to see
Advertisement

ATNM vs RVXCF

Header iconATNM vs RVXCF Comparison
Open Charts ATNM vs RVXCFBanner chart's image
Actinium Pharmaceuticals
Price$1.73
Change-$0.05 (-2.81%)
Volume$300
Capitalization55.53M
Resverlogix
Price$0.08
Change+$0.01 (+14.29%)
Volume$30K
Capitalization21.3M
ATNM vs RVXCF Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. RVXCF commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and RVXCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (ATNM: $1.78 vs. RVXCF: $0.08)
Brand notoriety: ATNM and RVXCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 49% vs. RVXCF: 86%
Market capitalization -- ATNM: $55.53M vs. RVXCF: $21.3M
ATNM [@Biotechnology] is valued at $55.53M. RVXCF’s [@Biotechnology] market capitalization is $21.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileRVXCF’s FA Score has 1 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • RVXCF’s FA Score: 1 green, 4 red.
According to our system of comparison, RVXCF is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while RVXCF’s TA Score has 3 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 3 bearish.
  • RVXCF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than RVXCF.

Price Growth

ATNM (@Biotechnology) experienced а +2.30% price change this week, while RVXCF (@Biotechnology) price change was +7.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($55.5M) has a higher market cap than RVXCF($21.3M). RVXCF YTD gains are higher at: 104.109 vs. ATNM (41.270). RVXCF has higher annual earnings (EBITDA): -10.54M vs. ATNM (-43.43M). ATNM has more cash in the bank: 59.9M vs. RVXCF (153K). ATNM has less debt than RVXCF: ATNM (1.29M) vs RVXCF (17.6M). ATNM (0) and RVXCF (0) have equivalent revenues.
ATNMRVXCFATNM / RVXCF
Capitalization55.5M21.3M261%
EBITDA-43.43M-10.54M412%
Gain YTD41.270104.10940%
P/E RatioN/AN/A-
Revenue00-
Total Cash59.9M153K39,150%
Total Debt1.29M17.6M7%
FUNDAMENTALS RATINGS
ATNM vs RVXCF: Fundamental Ratings
ATNM
RVXCF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
1050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVXCF's Valuation (25) in the null industry is somewhat better than the same rating for ATNM (71) in the Biotechnology industry. This means that RVXCF’s stock grew somewhat faster than ATNM’s over the last 12 months.

RVXCF's Profit vs Risk Rating (100) in the null industry is in the same range as ATNM (100) in the Biotechnology industry. This means that RVXCF’s stock grew similarly to ATNM’s over the last 12 months.

ATNM's SMR Rating (99) in the Biotechnology industry is in the same range as RVXCF (100) in the null industry. This means that ATNM’s stock grew similarly to RVXCF’s over the last 12 months.

RVXCF's Price Growth Rating (35) in the null industry is in the same range as ATNM (43) in the Biotechnology industry. This means that RVXCF’s stock grew similarly to ATNM’s over the last 12 months.

RVXCF's P/E Growth Rating (94) in the null industry is in the same range as ATNM (100) in the Biotechnology industry. This means that RVXCF’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMRVXCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
77%
Momentum
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
72%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 5 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
68%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NHHHF0.06N/A
+5.56%
FUELPOSITIVE CORP.
NRBT0.02N/A
N/A
Novus Robotics, Inc.
AGESF70.95N/A
N/A
ageas SA/NV
MTMV1.10N/A
N/A
MOTOMOVA INC.
TDBOY28.11N/A
N/A
Toyota Boshoku Corp.

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with IPSC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+2.30%
IPSC - ATNM
48%
Loosely correlated
-1.68%
CRBU - ATNM
45%
Loosely correlated
-3.61%
RXRX - ATNM
43%
Loosely correlated
-3.39%
ADVM - ATNM
42%
Loosely correlated
+1.65%
PRME - ATNM
41%
Loosely correlated
-5.81%
More

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
+9.86%
FULC - RVXCF
25%
Poorly correlated
-2.56%
TELIF - RVXCF
23%
Poorly correlated
+5.72%
ATNM - RVXCF
22%
Poorly correlated
+2.30%
NGNE - RVXCF
21%
Poorly correlated
-1.91%
IDYA - RVXCF
20%
Poorly correlated
-1.52%
More